|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/495 | |
| A61P 9/10 | |||
| G01N 33/68 | |||
| A61K 9/08 | |||
| A61K 9/22 |
| (11) | Patento numeris | 2170333 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08732776.3 |
| Europos patento paraiškos padavimo data | 2008-03-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-04-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-02-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/058063 |
| Data | 2008-03-24 |
| (87) | Numeris | WO 2008/150565 |
| Data | 2008-12-11 |
| (30) | Numeris | Data | Šalis |
| 941210 P | 2007-05-31 | US |
| (72) |
BLACKBURN, Brent, US
JERLING, Marcus, SE
WOLFF, Andrew, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE |
| RANOLAZINE FOR ELEVATED BRAIN-TYPE NATRIURETIC PEPTIDE |